Latest News
Scientists to begin human trials of cancer vaccine using AstraZeneca technology
Researchers in the UK and Germany will begin human trials for a therapeutic cancer vaccine "shortly" that uses the same technology as AstraZeneca's Covid-19 shot.
US services sector continues fast growth in August despite supply shortages
Services sector activity in the US continued expanding at a brisk pace in August, the results of a closely-followed survey revealed.
US jobs growth slows sharply as Delta rolls across country
Hiring in the US slowed sharply last month as the Delta variant of Covid-19 rolled across the country, particularly in the Southeast.
Europe close: Stocks end week on down note after US jobs report
European stocks finished the week on a down note as investors digested a weaker than expected reading on US non-farm payrolls.
JPMorgan lowers target price on Asos
Analysts at JPMorgan lowered their target price on online clothing retailer Asos from 6,800. 0p to 6,680. 0p on Friday following its full-year 2021 results preview.
Eurozone business activity stays strong in August
Eurozone business activity held strong in August despite concerns over the Covid-19 delta variant and global supply chain woes.
Beijing proposes investment in ride-hailing giant Didi
Beijing has proposed an investment that would see it take control of Didi Global, China's largest ride-hailing firm.
London close: Stocks end lower after US jobs report
London stocks finished lower on Friday following the release of weaker-than-expected US non-farm payrolls numbers which served to push the pound higher.
Week ahead: China data, ECB decision in the spotlight
Investors will be treated to a raft of key economic releases out of the People's Republic of China over the coming week.
US close: Stocks positive as initial jobless claims fall
Wall Street stocks closed in the green on Thursday, as investors digested a number of key data points.
US open: Dow Jones heads south after disappointing nonfarm jobs report
Major indices were mostly lower early on Friday as market participants digested a nonfarm payrolls report that came in significantly lower than forecast.
Broker tips: Asos, Eurocell, Polymetal
Analysts at JPMorgan lowered their target price on online clothing retailer Asos from 6,800. 0p to 6,680. 0p on Friday following its full-year 2021 results preview.
Director dealings: Barratt Developments chairman raises stake
Barratt Developments revealed on Friday that chairman John Allan had acquired 5,530 ordinary shares in the FTSE 100-listed housebuilder.
FTSE 250 movers: Discoverie rallies; Ashmore loses ground after results
London’s FTSE 250 was down 0. 2% at 24,170 in afternoon trade on Friday.
FTSE 100 movers: Melrose rises again; Ocado in the red
London's FSE0 100 was down 0. 4% at 7,137. 52 in afternoon trade on Friday as investors mulled the latest non-farm payrolls report.
JD.com to buy controlling stake in China Logistics
Chinese online retailer JD. com said on Friday that its subsidiary, JD Property, has agreed to buy a controlling stake in China Logistics in a $2. 1bn deal.
Europe midday: Investors hold fire ahead of US non-farm payrolls
European stocks were lower at midday on Friday as investors took a cautious stance ahead of US non-farm payroll numbers.
US pre-open: Futures trade higher ahead of nonfarm payrolls report
Wall Street futures were trading slightly higher ahead of the bell on Friday as market participants eagerly awaited the release of last month's nonfarm payrolls report later in the day.
London midday: Stocks edge up as investors eye payrolls
London stocks had edged higher by midday on Friday but gains were muted as investors eyed the release of the US non-farm payrolls report.
Cinven pulls out of race for UK's Sanne
Private equity firm Cinven has pulled out of the£1. 5bn race to buy UK British asset management services provider Sanne, paving the way for a takeover by US-based fund servicer Apex Group.
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.